Hijacking Human Rights in Latin America
By Gina Maranto, Biopolitical Times guest contributor
| 05. 03. 2011
In 2009, a Buenos Aires civic association awarded a prize named after American civil rights activist Rosa Parks to Argentinian Senator Liliana Negre de Alonso. The prize was given “por la Defensoría de la Vida Humana,” but the recipient’s resumé hardly resembles that of a typical human rights advocate. Negre de Alonso has a history of opposing laws and policies that favor sexual and reproductive choice. In 2006, for instance, she fought against a bill that sought to provide all Argentinians access to free vasectomies or tubal ligations. Among other things, she argued that it would promote HIV transmission by lessening the need for condoms. She has long opposed abortion, and last year, she waged a highly emotional campaign against Argentina’s landmark same-sex marriage law.
Negre de Alonso, a member of the highly conservative Opus Dei movement, which defines itself as the “personal prelature of the Catholic Church”, was exhibit Number One in a recent talk by anthropologist Lynn Morgan at the University of Miami. Morgan, the Mary E. Woolley Professor of Anthropology at...
Related Articles
Flag of South Africa; design by Frederick Brownell,
image by WikimediaCommons users.
Public domain, via Wikimedia Commons
What is the legal status of heritable human genome editing (HHGE)? In 2020, a comprehensive policy analysis by Baylis, Darnovsky, Hasson, and Krahn documented that more than 70 countries and an international treaty prohibit it, and that no country explicitly permits it. Policies in some countries were non-existent, ambiguous, or subject to possible amendment, but the general rule remained, even after one...
By Bernice Lottering, Gene Online | 11.08.2024
South Africa’s updated health-research ethics guidelines, which now include heritable human genome editing, have sparked concern among scientists. The revisions, made in May but only recently gaining attention, outline protocols for modifying genetic material in sperm, eggs, or embryos—changes that...
By Jim Thomas, Scan the Horizon | 11.19.2024
It’s the wee hours of 2nd November 2024 in Cali, Colombia. In a large UN negotiating hall Colombian Environment Minister Susana Muhamed has slammed down the gavel on a decision that should send a jolt through the AI policy world. ...
By Ned Pagliarulo, BioPharmaDive | 11.05.2024
A medicine built around a more precise form of CRISPR gene editing appeared to work as designed in its first clinical trial test, developer Beam Therapeutics said Tuesday. But the death of a trial participant could renew concerns about an older...